Supplementary Table 1 from Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer
作者
Stephanie L. Wethington,Payal Deepak Shah,Lainie P. Martin,Janos Laszlo Tanyi,Nawar Latif,Mark Aloysuis Morgan,Drew A. Torigian,Diego Rodriguez,Simon A. Smith,Emma Jane Dean,Susan M. Domchek,Ronny Drapkin,Ie‐Ming Shih,Eric J. Brown,Wei‐Ting Hwang,Deborah Kay Armstrong,Stephanie L. Gaillard,Robert Lawrence Giuntoli,Fiona A. Simpkins
PDF的下载单位、IP信息已删除
(2025-6-4)
null
无极微光
DW
CarryLJR
v0id
极限001
坚强冰枫
aaaa
zhixiang
朱帅
xing_xing
mmmm
T_Y_C_6_6_6
柚子
Elsevier大王
kaio_escolar
mxr
学霸业
prigogin
初景
皖公网安备34019202002308
